Show simple item record

dc.contributor.authorFlaherty, RL
dc.contributor.authorSflomos, G
dc.contributor.authorBrisken, C
dc.coverage.spatialUnited States
dc.date.accessioned2024-06-25T11:27:35Z
dc.date.available2024-06-25T11:27:35Z
dc.date.issued2024-03-29
dc.identifierARTN bqae031
dc.identifier7637246
dc.identifier.citationEndocrinology, 2024, 165 (5), pp. bqae031 -en_US
dc.identifier.issn0013-7227
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/6270
dc.identifier.eissn1945-7170
dc.identifier.eissn1945-7170
dc.identifier.doi10.1210/endocr/bqae031
dc.identifier.doi10.1210/endocr/bqae031
dc.description.abstractLobular carcinoma represent the most common special histological subtype of breast cancer, with the majority classed as hormone receptor positive. Rates of invasive lobular carcinoma in postmenopausal women have been seen to increase globally, while other hormone receptor-positive breast cancers proportionally have not followed the same trend. This has been linked to exposure to exogenous ovarian hormones such as hormone replacement therapy. Reproductive factors resulting in increased lifetime exposure to endogenous ovarian hormones have also been linked to an increased risk of lobular breast cancer, and taken together, these data make a case for the role of ovarian hormones in the genesis and progression of the disease. In this review, we summarize current understanding of the epidemiological associations between ovarian hormones and lobular breast cancer and highlight mechanistic links that may underpin the etiology and biology.
dc.formatPrint
dc.format.extentbqae031 -
dc.languageeng
dc.language.isoengen_US
dc.publisherENDOCRINE SOCen_US
dc.relation.ispartofEndocrinology
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.subjectandrogenic progestins
dc.subjectestrogen receptor
dc.subjecthormonal contraception
dc.subjecthormone replacement therapy
dc.subjectinvasive lobular carcinoma
dc.subjectprogesterone receptor
dc.subjectFemale
dc.subjectHumans
dc.subjectCarcinoma, Lobular
dc.subjectProgestins
dc.subjectEstrogens
dc.subjectBreast Neoplasms
dc.subjectHormone Replacement Therapy
dc.subjectRisk Factors
dc.titleIs There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?en_US
dc.typeJournal Article
dcterms.dateAccepted2024-03-29
dc.date.updated2024-06-25T11:26:04Z
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1210/endocr/bqae031en_US
rioxxterms.licenseref.startdate2024-03-29
rioxxterms.typeJournal Article/Reviewen_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38551031
pubs.issue5
pubs.organisational-groupICR
pubs.organisational-groupICR/Primary Group
pubs.organisational-groupICR/Primary Group/ICR Divisions
pubs.organisational-groupICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-groupICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrine control mechanisms
pubs.publication-statusPublished
pubs.publisher-urlhttp://dx.doi.org/10.1210/endocr/bqae031
pubs.volume165
icr.researchteamEndocrine control mechansen_US
dc.contributor.icrauthorBrisken, Cathrin
icr.provenanceDeposited by Mr Arek Surman on 2024-06-25. Deposit type is initial. No. of files: 1. Files: bqae031.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/